Device Trial Radar · NCT04283149
Multicenter Clinical Trial of a Phakic Implantable Collamer® Lens (ICL)
Last checked: Nov 19, 2026Latest source record: Mar 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
327
Actual
Start
Jan 30, 2020
Primary completion
Apr 5, 2021
Study completion Dec 15, 2023
Sponsor
- Lead sponsor
- Staar Surgical CompanyNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 25, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years, up to 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This objective of this study is to evaluate the safety, and to collect supportive data on effectiveness of the EVO/EVO+ Visian® Implantable Collamer® Lens (ICL) in study participants who have a diagnosis of myopia or myopia with astigmatism. Primary study analysis will be evaluated when 300 primary eyes complete 6 months of follow-up. Final study analysis will be assessed when all treated eyes complete 36 months of follow-up.
Conditions
- Myopia
- Myopic Astigmatism
Interventions
EVO/EVO+ Visian ICLDevice
The investigational lenses are intended to be implanted within the posterior chamber, directly behind the iris, and in front of the anterior capsule of the human crystalline lens.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Primary Eyes Requiring Peripheral Iridotomy (PI)Time frame: 6 Months
- Endothelial Cell Density (ECD) Change in Primary Eyes.Time frame: 6 Months
- Endothelial Cell Density (ECD) <1000 Cells/mm² in Primary Eyes.Time frame: 6 months
2 more outcomes with a free account
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
Barnett Dulaney Perkins
Phoenix, Arizona
Aloha Laser Vision, LLC
Honolulu, Hawaii
Price Vision Group,
Indianapolis, Indiana
11 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.